A detailed history of Victory Capital Management Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 10,316 shares of CRBU stock, worth $20,013. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,316
Previous 10,231 0.83%
Holding current value
$20,013
Previous $52,000 69.23%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$1.62 - $5.05 $137 - $429
85 Added 0.83%
10,316 $16,000
Q1 2024

May 03, 2024

BUY
$4.82 - $8.26 $49,313 - $84,508
10,231 New
10,231 $52,000
Q1 2022

May 04, 2022

SELL
$8.42 - $15.32 $683,367 - $1.24 Million
-81,160 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$14.59 - $23.26 $55,004 - $87,690
-3,770 Reduced 4.44%
81,160 $1.23 Million
Q3 2021

Nov 02, 2021

BUY
$15.75 - $30.29 $1.34 Million - $2.57 Million
84,930 New
84,930 $2.03 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $118M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.